Merck, a leading science and technology company, has opened its new Asia-Pacific Bioprocessing Production Centre in Daejeon, ...

Singapore’s RACES study finds higher-risk node-negative early breast cancer patients had similar seven-year recurrence or death rates to node-positive patients.

Once-weekly insulin is opening a new commercial frontier in diabetes care, with pharmaceutical companies betting that fewer ...

Asia Pacific is helping set the next milestone in global action on breast cancer. ASEAN’s latest decision to elevate breast ...

As AI becomes increasingly embedded in healthcare, a critical flaw is emerging: the data powering these systems often fails ...

Vietnam is emerging as a regional leader in precision reproductive healthcare, integrating AI-driven embryology, advanced ...

As the world observes World AMR Awareness Week (WAAW) from November 18 to 24, 2026, the focus is increasingly shifting ...

As antimicrobial resistance (AMR) continues to threaten patient safety and healthcare outcomes across Asia, the need for responsible antibiotic use has become increasingly urgent. Ahead of World AMR ...

A final day on neurotechnology, AI drug discovery that must prove its value and a live brain-computer interface demonstration ...

Fund has announced a total investment of approximately JPY 1.06 billion ($6.8 million) in nine R&D projects for the ...

BioMarin signs deal worth $475 M with Korea's GC Biopharma and Hanmi Pharm for potential treatment of Fabry Disease ...

Under the agreement, Astellas receives an exclusive option which, on exercise, will grant Astellas a worldwide license to ...